ADVIA CENTAUR XPT CA 15-3 ASSAY N/A 10327620

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a foreign,health professional,u report with the FDA on 2016-03-18 for ADVIA CENTAUR XPT CA 15-3 ASSAY N/A 10327620 manufactured by Siemens Healthcare Diagnostics, Inc..

Event Text Entries

[40728058] The customer suspected the reagent readypack due to extremely low quality control and patient results. The customer stores some of their readypacks in closed boxes when in the refrigerator. The refrigerator where the readypacks are stored has glass doors and sometimes the internal light below the readypacks was left on. The customer cannot say whether the boxes are close to the light. Siemens healthcare diagnostics recommended to the customer to store ca15-3 reagent kits as far away from the light as possible. The cause for the discordant advia centaur xpt ca15-3 results is unknown. The instrument is performing within specifications. No further evaluation of the device is required. The ifu states in the storing and stability section: "store the reagents upright at 2-8? C. Protect reagent packs from all heat and light sources. Reagent packs loaded on the system are protected from light. Store unused reagent packs at 2-8? C away from heat and light sources. All reagents are stable at 2-8? C until the expiration date on the packaging. " the ifu states in the limitation section: "note: do not interpret levels of ca 15-3 as absolute evidence of the presence or the absence of malignant disease. Before treatment, patients with confirmed breast carcinoma frequently have levels of ca 15-3 within the range observed in healthy individuals. Additionally, elevated levels of ca 15-3 can be observed in patients with nonmalignant diseases. Measurements of ca 15-3 should always be used in conjunction with other diagnostic procedures, including information from the patient's clinical evaluation. " note: product availability may vary from country to country and is subject to varying regulatory requirements. Due to local regulations, the advia centaur xpt is not available in all countries.
Patient Sequence No: 1, Text Type: N, H10


[40728059] Discordant advia centaur xpt ca 15-3 results were obtained for samples from two patients. The initial results were low. The customer suspected the reagent readypack was defective. The patient samples were repeated on another instrument with a different reagent readypack. The repeat results were high. Patient treatment was not prescribed or altered. There was no report of adverse health consequences due to the discordant ca 15-3 results.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number1219913-2016-00056
MDR Report Key5512152
Report SourceFOREIGN,HEALTH PROFESSIONAL,U
Date Received2016-03-18
Date of Report2016-02-25
Date of Event2016-02-23
Date Mfgr Received2016-02-25
Device Manufacturer Date2015-06-18
Date Added to Maude2016-03-18
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Reporter OccupationOTHER HEALTH CARE PROFESSIONAL
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactMS. EIMAN SULIEMAN
Manufacturer Street333 CONEY STREET
Manufacturer CityE. WALPOLE MA 02032
Manufacturer CountryUS
Manufacturer Postal02032
Manufacturer Phone5086604603
Manufacturer G1SIEMENS HEALTHCARE DIAGNOSTICS, INC.
Manufacturer Street333 CONEY STREET
Manufacturer CityE. WALPOLE MA 02032
Manufacturer CountryUS
Manufacturer Postal Code02032
Single Use3
Remedial ActionIN
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameADVIA CENTAUR XPT CA 15-3 ASSAY
Generic NameCA 15-3 IMMUNOASSAY
Product CodeMOI
Date Received2016-03-18
Model NumberN/A
Catalog Number10327620
Lot Number043159
Device Expiration Date2016-06-18
OperatorHEALTH PROFESSIONAL
Device AvailabilityN
Device Eval'ed by MfgrN
Device Sequence No1
Device Event Key0
ManufacturerSIEMENS HEALTHCARE DIAGNOSTICS, INC.
Manufacturer Address511 BENEDICT AVENUE TARRYTOWN NY 105915097 US 105915097


Patients

Patient NumberTreatmentOutcomeDate
10 2016-03-18

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.